• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Scleroderma Center

Show Search
Hide Search
  • About The Center
    • How We Are Different
    • About the Area
    • News from the Johns Hopkins Scleroderma Center
  • About Scleroderma
    • Types of Scleroderma
    • Frequently Asked Questions
    • Comprehensive Care
  • For Patients
    • Make An Appointment
    • What To Expect
    • Living with Scleroderma
    • Scleroderma Treatment Options
    • Patient Resources
  • For Physicians
    • Physician Resources
    • Referral Instructions
  • Our Research
    • Publications
    • Clinical and Translational Research
    • Clinical Trials and Observational Studies
  • Donate
Home / About The Center / How We Are Different

How We Are Different

Scleroderma is a Treatable Disease

While the doctors at The Johns Hopkins Scleroderma Center search for a cure for scleroderma, they are successfully treating the disease manifestations and reducing the suffering caused by scleroderma.  They also educate patients and their families about scleroderma and what is the best treatment approach.

Experts in an Uncommon Disease

Since 1992, the Johns Hopkins Scleroderma Center has attracted thousands of patients from all over the world.  Since the early days of the Johns Hopkins Scleroderma Center, Founder Dr. Fredrick Wigley and his team have turned to their Hopkins’ colleagues for their expert help in the treatment of his patients. Johns Hopkins is home to renowned doctors who specialize in every aspect of the disease and all areas of the body affected by scleroderma.  The success of The Johns Hopkins Scleroderma Center reflects the strength and cohesiveness of this extraordinary group.

Using Research to understand Scleroderma

Thanks to patients of The Johns Hopkins Scleroderma Center, Dr. Wigley and his colleagues have built one of the largest resources to do research on scleroderma in the world. This includes a repository—containing data and blood and tissue samples from patients who chose to participate.  These materials are available to researchers studying the biological causes of scleroderma, patterns of the disease, potential new treatments, and much more.

Over a dozen scleroderma research studies (basic science, clinical trials, and epidemiology) are underway at Johns Hopkins.  The Center’s researchers interact with other investigators within Johns Hopkins, other academic Institutions around the world, the National Institutes of Health (NIH), and industries involved in developing new medications and treatments.   Dr. Wigley and his team are finding answers and are continuing to use the evidence to reach their ultimate goal of finding a cure for scleroderma.

Learn more about our comprehensive care.

Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Use of this Site

All information contained within the Johns Hopkins Scleroderma website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar


donate to the Johns Hopkins Scleroderma Center

Contact Our Center

Johns Hopkins Scleroderma Center
Johns Hopkins Asthma & Allergy Center
Division of Rheumatology, 1st Floor, Room 1B7
5501 Hopkins Bayview Circle
Baltimore, Maryland 21224-6801
Phone: (410) 550-7715
Fax: (410) 367-2371

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Arthritis Center
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube
U.S. News and World Report Rankings Badge

Johns Hopkins Medicine

© 2023 Johns Hopkins Scleroderma Center
Patient Privacy